Since we observed BCL2L10 transactivation by STAT3 in the model cell line HEK293, it is very likely that STAT3 drives BCL2L10 upregulation in other tumor types presenting constitutive activity of STAT3. The gene discussed is BCL2L10; the disease is neoplasm.